biovisionK896-100CYP2C9 inhibitor screening kit, CYP2C9 inhibitor kit, CYP inhibitor screening, screen cytochrome P450 inhibitors, study Cytochrome P450 2C9 inhibitors, characterize CYP inhibitors, characterize CYP ligands, CYP2C9 inhibitor, CYP2C inhibitor screening kit, cyp2c inhibitor kit, cytochrome inhibitor screening, screen cyp2c9 inhibitors, screen cyp2c ligands, screen CYP2C9 inhibitors, CYP2C9 ligands, study cytochrome P450 2C9 inhibitors, characterize cyp2C9 inhibitors, Cyt P450 inhibitor, Cyt P450 2C9 drug screening, Cytochrome P450 ligand screening kit, Cyp2C9 ligand screening kit, CYP2C9 inhibitor screening, screen inhibitors of CYP enzymes, study cytochrome P450 inhibitors, characterize CYP inhibitors, Cytochrome P450 ligands, cytochrome P450 2C9, November-AK-15 ? Detection method - Fluorescence (Ex/Em 415/502 nm) ? Species reactivity - Eukaryotes ? Applications - ? Rapid assessment of native/recombinant CYP2C9 activity in lysates or microsomal fractions prepared from tissues, cells. ? Screening of drugs and novel ligands for interaction with native/recombinant CYP2C9. ? Rapid, high-throughput screening of drugs and novel ligands. ? Development of structure-activity relationship (SAR) models to predict CYP2C9 inhibition liability of novel compounds. ? Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP2C9.Samples containing drugs, inhibitors or ligands (compounds that can interact and affect CYP2C9 activity)